⌘K
Loading ticker…
Eledon Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Eledon Pharmaceuticals, Inc. Common Stock (ELDN) has a 3-month relative strength percentile of 79 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 68. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.1%, relative volume 4.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 79, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
ELDN is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $7M notional. Top 3 carry $15M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $7M |
| IWMiShares Russell 2000 ETF | 0.01% | $6M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $122K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELDN Jan avg: 24.98% median: 27.66% win: 75% σ: 24.28% n: 4 2022-04-12 → 2026-05-29 | ELDN Feb avg: -4.22% median: -3.53% win: 50% σ: 19.98% n: 4 2022-04-12 → 2026-05-29 | ELDN Mar avg: 3.42% median: 7.22% win: 75% σ: 16.38% n: 4 2022-04-12 → 2026-05-29 | ELDN Apr avg: 1.44% median: -6.78% win: 40% σ: 14.39% n: 5 2022-04-12 → 2026-05-29 | ELDN May avg: 3.78% median: 4.25% win: 80% σ: 7.43% n: 5 2022-04-12 → 2026-05-29 | ELDN Jun avg: -17.98% median: -16.59% win: 0% σ: 13.87% n: 4 2022-04-12 → 2026-05-29 (current) | ELDN Jul avg: 12.92% median: 13.80% win: 100% σ: 9.50% n: 4 2022-04-12 → 2026-05-29 | ELDN Aug avg: 3.13% median: 2.86% win: 50% σ: 18.29% n: 4 2022-04-12 → 2026-05-29 | ELDN Sep avg: -11.91% median: -10.63% win: 0% σ: 10.90% n: 4 2022-04-12 → 2026-05-29 | ELDN Oct avg: 38.68% median: 40.33% win: 75% σ: 46.02% n: 4 2022-04-12 → 2026-05-29 | ELDN Nov avg: -21.77% median: -13.03% win: 50% σ: 29.85% n: 4 2022-04-12 → 2026-05-29 | ELDN Dec avg: 7.75% median: -6.96% win: 25% σ: 32.59% n: 4 2022-04-12 → 2026-05-29 |